Evidence for Association Between OXTR Gene and ASD Clinical Phenotypes

Area of Science:

• Neurogenetics
• Autism Spectrum Disorder Research
• Molecular Psychiatry

Background:

• Autism spectrum disorder (ASD) is a neurodevelopmental condition affecting social and communication skills.
• The oxytocin system, including the oxytocin receptor gene (OXTR), is implicated in social behaviors and potentially in ASD etiology.
• Investigating genetic variations in OXTR is crucial for understanding ASD's complex genetic underpinnings.

Purpose of the Study:

• To evaluate the impact of two OXTR gene polymorphisms (rs1042778 and rs53576) on ASD diagnosis.
• To assess the association of these polymorphisms with specific ASD-related clinical symptoms, including seizures, panic, and aggressive behaviors.
• To explore potential effects of these single nucleotide polymorphisms (SNPs) on OXTR gene availability and function using bioinformatics.

Main Methods:

• A family-based genetic association study involving 209 probands with ASD and their parents.
• Logistic regression models were employed to analyze the association between OXTR polymorphisms and ASD outcomes.
• Bioinformatic analysis was conducted to predict the functional consequences of the identified SNPs on OXTR gene regulation.

Main Results:

• The rs1042778 T allele showed nominal associations with panic and aggressive behaviors in individuals with ASD.
• A trend towards association between the rs1042778 G allele and ASD susceptibility was observed in the family-based analysis.
• Bioinformatic analysis indicated that the rs1042778 G allele influences transcription factor MAZ binding, potentially affecting OXTR gene transcription levels.

Conclusions:

• The OXTR gene, particularly the rs1042778 polymorphism, may play a role in ASD diagnosis and specific clinical phenotypes.
• Findings suggest a potential mechanism involving altered OXTR gene expression due to rs1042778 variations.
• Further research is warranted to validate these findings and elucidate the role of the oxytocin pathway in ASD.